- Investing Ideas
- Software Healthcare Sector
Software Healthcare Sector
Results
2165
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2165 companies
Bicara Therapeutics
Market Cap: US$1.8b
A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.
BCAX
US$28.15
7D
0.2%
1Y
145.9%
Palvella Therapeutics
Market Cap: US$1.8b
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases.
PVLA
US$143.94
7D
-3.8%
1Y
299.8%
Sarepta Therapeutics
Market Cap: US$1.8b
A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases.
SRPT
US$16.21
7D
-9.7%
1Y
19.1%
AbCellera Biologics
Market Cap: US$1.8b
Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.
ABCL
US$5.97
7D
-11.4%
1Y
21.3%
AtriCure
Market Cap: US$1.8b
Engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally.
ATRC
US$34.51
7D
0.5%
1Y
17.5%
Butterfly Network
Market Cap: US$1.8b
Develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.
BFLY
US$6.82
7D
-12.0%
1Y
260.8%
Bausch Health Companies
Market Cap: US$1.7b
Operates as a diversified specialty pharmaceutical and medical device company.
BHC
US$4.52
7D
-4.8%
1Y
-30.6%
Teladoc Health
Market Cap: US$1.7b
Provides virtual healthcare services worldwide.
TDOC
US$9.71
7D
4.7%
1Y
15.3%
Generate Biomedicines
Market Cap: US$1.7b
Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States.
GENB
US$14.39
7D
1.3%
1Y
n/a
Immunocore Holdings
Market Cap: US$1.7b
Engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and autoimmune disease in the United States, Europe, and internationally.
IMCR
US$34.48
7D
3.0%
1Y
-7.2%
Stoke Therapeutics
Market Cap: US$1.7b
Engages in the development of treatments for severe genetic diseases by upregulating protein expression.
STOK
US$28.81
7D
-1.1%
1Y
112.3%
Zymeworks
Market Cap: US$1.7b
A biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases.
ZYME
US$24.05
7D
-2.5%
1Y
67.9%
Trulieve Cannabis
Market Cap: US$1.7b
Operates as a cannabis retailer in the United States.
TRLV
US$8.96
7D
-1.1%
1Y
102.8%
Fortrea Holdings
Market Cap: US$1.7b
A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
FTRE
US$17.91
7D
-0.7%
1Y
208.8%
Alamar Biosciences
Market Cap: US$1.7b
A proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases.
ALMR
US$25.15
7D
-7.0%
1Y
n/a
Harrow
Market Cap: US$1.7b
An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States.
HROW
US$43.71
7D
5.7%
1Y
21.0%
ANI Pharmaceuticals
Market Cap: US$1.6b
A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
ANIP
US$79.15
7D
-1.7%
1Y
19.3%
MapLight Therapeutics
Market Cap: US$1.6b
Operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders.
MPLT
US$37.44
7D
-1.2%
1Y
n/a
Recursion Pharmaceuticals
Market Cap: US$1.6b
A clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom.
RXRX
US$3.08
7D
-6.9%
1Y
-52.1%
COMPASS Pathways
Market Cap: US$1.6b
Operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States.
CMPS
US$12.18
7D
-9.0%
1Y
175.6%
MoonLake Immunotherapeutics
Market Cap: US$1.6b
A clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases.
MLTX
US$20.06
7D
2.8%
1Y
-62.6%
Innoviva
Market Cap: US$1.6b
Operates as a biopharmaceutical company in the United States and internationally.
INVA
US$21.58
7D
-0.7%
1Y
11.9%
Maze Therapeutics
Market Cap: US$1.6b
A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidney and metabolic diseases in the United States.
MAZE
US$29.30
7D
-1.9%
1Y
73.0%
Xeris Biopharma Holdings
Market Cap: US$1.6b
A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.
XERS
US$8.78
7D
6.0%
1Y
71.5%
Vir Biotechnology
Market Cap: US$1.6b
A clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally.
VIR
US$9.42
7D
-0.7%
1Y
64.4%
Green Thumb Industries
Market Cap: CA$2.2b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$9.91
7D
-6.1%
1Y
24.0%
Enovis
Market Cap: US$1.5b
A medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally.
ENOV
US$27.10
7D
9.9%
1Y
-0.5%
Inspire Medical Systems
Market Cap: US$1.5b
A medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
INSP
US$52.49
7D
6.8%
1Y
-59.4%
Intellia Therapeutics
Market Cap: US$1.5b
Operates as a clinical-stage genome editing company focused on developing potentially curative therapeutics using CRISPR/Cas9-based technologies.
NTLA
US$11.47
7D
-13.8%
1Y
-15.0%
InnovAge Holding
Market Cap: US$1.5b
Manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities.
INNV
US$11.84
7D
2.0%
1Y
205.2%
Ardent Health
Market Cap: US$1.5b
Owns and operates a network of hospitals and clinics that provides healthcare services in the United States.
ARDT
US$10.45
7D
6.6%
1Y
-0.6%
Neuren Pharmaceuticals
Market Cap: AU$2.1b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$16.76
7D
0.4%
1Y
6.4%
AnaptysBio
Market Cap: US$1.5b
A clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States.
ANAB
US$53.76
7D
-14.0%
1Y
105.1%
Integra LifeSciences Holdings
Market Cap: US$1.5b
Manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.
IART
US$19.01
7D
3.3%
1Y
57.8%
Perrigo
Market Cap: US$1.5b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO
US$10.47
7D
5.8%
1Y
-62.0%
AdaptHealth
Market Cap: US$1.5b
Distributes home medical equipment (HME), medical supplies, and home and related services in the United States.
AHCO
US$11.21
7D
10.0%
1Y
18.2%